U.S. federal trademark · Serial No. 78117241 · Reg. No. 3356991
[ Pharmaceutical preparations and vaccines for the treatment of myocardial infarction, cancer, multiple sclerosis, stroke, sepsis, heredity deficiency of the molecule leading to increased thrombolytic events, and heparin resistance in medical procedures; biologics; cells, cell lines and cell cultures for medical and clinical use in the production of proteins for therapeutic and diagnostic use; ] proteins [ and cloned DNA ] from [ humans, plants, ] animals [, bacteria and other micro-organisms ] for use as medical therapeutic reagents; transgenic and cloned animal products, namely, [ meat, tissue, cells or ] secretions for therapeutic and diagnostic use
[ Custom manufacture of transgenic animal products, namely, pharmaceuticals, biopharmaceuticals and proteins ]
[ Providing technical advice, research, testing and analysis in the field of pharmaceutical drug development; pharmaceutical drug development ]
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.